WuXi Biologics (Cayman) Inc. (HKG: 2269)
Hong Kong
· Delayed Price · Currency is HKD 18.46
-0.24 (-1.28%)
Jan 21, 2025, 1:01 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 76.61 billion as of January 17, 2025. Its market cap has decreased by -34.04% in one year.
Market Cap
76.61B
Enterprise Value
75.56B
Revenue
18.39B
Ranking
n/a
PE Ratio
29.01
Stock Price
18.46
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 76.61B, an increase of 139.11%. That is a compound annual growth rate of 12.14%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 174.25B |
| Hansoh Pharmaceutical Group Company | 100.77B |
| JD Health International | 94.84B |
| Sinopharm Group | 62.23B |
| Alibaba Health Information Technology | 54.36B |
| Akeso | 53.67B |
| Sino Biopharmaceutical | 52.37B |
| Innovent Biologics | 50.86B |